Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details


Value, Access and Regulatory Strategy Workshop

Breakdown silos to facilitate increased access to new medicines

Add this event to your calendar: iCal   Google Calendar


Leaders across industry and health authorities agree that finding answers to market access are critical to the future of delivering breakthrough medicines to patients. Unfortunately, policies and practice do not always marry up.

This meeting is the starting point to engage professionals working with value and regulatory strategies. HTA bodies and regulators are breaking down silos, facilitating access to new medicines and increasing efficiencies in assessment processes. R&D process will need to be able to generate evidence for registration and reimbursement.

Bringing together the policy makers and the policy implementers, to keep you ahead of the game of practical solutions.


Speakers: Solange Corriol-Rohou (Senior Director, Globar RA & Policy, Astrazeneca), Angelika Joos (ED, Global Regulatory Policy, MSD), Katarzyna Kolasa (Senior Project Sales Director, Health Economics & Outcomes Research, GE Healthcare), Mira Pavlovic (Founder, MDT Services), Claudine Sapede (Global HTA & Payment Policy Lead, F. Hoffmann-La Roche)


Member Early-Bird: EUR 1230, Member Advance Rate: EUR 1330, Member Industry: EUR 1430, Non-Member Industry: EUR 1585, Member Government/Charitable/Non-profit/Academia (Full-Time): EUR 715, Non-member Government/Charitable/Non-profit/Academia (Full-Time): EUR 870


Customer Contact Center

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.